Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

被引：1
|
作者：
Hofer, Felix [1 ]
Hammer, Andreas [1 ]
Steinacher, Eva [1 ]
Baumer, Ulrike [1 ]
Kazem, Niema [1 ]
Koller, Lorenz [1 ]
Richter, Bernhard [1 ]
Hengstenberg, Christian [1 ]
Sulzgruber, Patrick [1 ]
Niessner, Alexander [1 ]
机构：
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2023年 / 9卷 / 06期
关键词：
D O I：
10.1093/ehjcvp/pvad022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：505 / 506
页数：2
相关论文
共 50 条
  • [31] RENAL EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED OR PRESERVED EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Boulmpou, Aristi
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Zografou, Ioanna
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E70 - E70
  • [32] Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors among patients with heart failure with preserved ejection fraction
    Riaz, Munaza
    Smith, Steven M.
    Dietrich, Eric A.
    Winchester, David E.
    Guo, Jingchuan
    Park, Haesuk
    PHARMACOTHERAPY, 2023, 43 (10): : 1024 - 1031
  • [33] When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney Disease
    O'Meara, Eileen
    Verma, Subodh
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (04) : 669 - 673
  • [34] Impact of Inpatient Initiation of Sodium-Glucose Cotransporter-2 Inhibitors on Prescription Rates in Patients With Heart Failure With Reduced Ejection Fraction
    Okoroike, Henry
    Patel, Sajni
    Simone, Pamela
    Lavelle, Rachel
    Szwak, Jennifer Austin
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 186 : 150 - 155
  • [35] Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
    Cheema, Huzaifa Ahmad
    Shafiee, Arman
    Athar, Mohammad Mobin Teymouri
    Rafiei, Mohammad Ali
    Mehmannavaz, Atefe
    Jafarabady, Kyana
    Shahid, Abia
    Ahmad, Adeel
    Ijaz, Sardar Hassan
    Dani, Sourbha S.
    Minhas, Abdul Mannan Khan
    Nashwan, Abdulqadir J.
    Fudim, Marat
    Fonarow, Gregg C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [36] Sodium-glucose transporter 2 inhibitors in heart failure with preserved ejection fraction
    Boehm, Michael
    Bauersachs, Johann
    KARDIOLOGIE, 2023, 17 (02): : 116 - 122
  • [37] Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis
    Treewaree, Sukrit
    Kulthamrongsri, Narathorn
    Owattanapanich, Weerapat
    Krittayaphong, Rungroj
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [38] The use of sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: new guidelines hot off the press and directly into guidelines!
    Clark, Katherine A. A.
    POSTGRADUATE MEDICAL JOURNAL, 2023, 99 (1176) : 1052 - 1057
  • [39] Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
    Fu, Edouard L.
    Patorno, Elisabetta
    Everett, Brendan
    Vaduganathan, Muthiah
    Solomon, Scott
    Levin, Raisa
    Schneeweiss, Sebastian
    Desai, Rishi
    CIRCULATION, 2022, 146
  • [40] Sodium-Glucose Cotransporter 2 Inhibitors Reduce Residual Cardiovascular Risk in Heart Failure With Preserved Ejection Fraction
    Sakai, Takaaki
    Miura, Shinichiro
    CIRCULATION, 2019, 140
12345